NCT00000899View on ClinicalTrials.gov

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2001

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

DRUG

Lamivudine

DRUG

Filgrastim

DRUG

Stavudine

DRUG

Cyclophosphamide

Trial Locations (2)

27710

Duke Univ Med Ctr, Durham

275997215

Univ of North Carolina, Chapel Hill

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000899 - A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients | Biotech Hunter | Biotech Hunter